Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Elbion AG closes €35mm venture round

Executive Summary

Elbion AG (inflammation and CNS therapeutics) has completed its first venture round, bringing in €35mm ($44mm) for the company. 3i, Burrill & Co., and DVC Deutsche Venture Capital co-led the financing and were joined by AGF Private Equity, Quintiles PharmaBio Development, BayTech Venture Capital, Marubeni Corp., TVM Techno Venture Management, Temasek Holdings, and Mitsubishi Corp.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies